stella
beta
A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer — Stella
Recruiting
Back to Gastric Cancer/Adenocarcinoma of Esophagogastric Junction trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Fudan University ShangHai Cancer Center, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov